Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-142069

Chief Financial Officer acquired 4,790 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ruffo Frank Chief Financial Officer 2016-09-15 Other acquisition +4,790 142,702 D: show line 1 in the form
Loading xslF345X03/doc4.xml…